Anti-obesity and anorectic effects of saffron and its constituent crocin in obese Wistar rat

Journal of Medicinal Plants

Volumn 14, Issue 53, 2015, Pages 25-33

  Kianbakht, S ^a   Hashem Dabaghian, F ^b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crocin; Crocus sativus; Obesity; Rat; Saffron

Indexed keywords

CROCIN; CROCUS SATIVUS EXTRACT; LEPTIN; METHANOL; SIBUTRAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANORECTIC EFFECT; ANTIOBESITY EFFECT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROCUS SATIVUS; DRUG EFFECT; FAT MASS; FOOD INTAKE; HORMONE BLOOD LEVEL; INSULIN SENSITIVITY; LEPTIN BLOOD LEVEL; MALE; NONHUMAN; OBESITY; PISTIL STIGMA; RAT; SOLVENT EXTRACTION; WISTAR RAT;

CROCUS SATIVUS; RATTUS; RATTUS NORVEGICUS;

EID: 84929145625     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aguilar-Valles A, Inoue W, Rummel C and Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacol. 2015 Jan 10. doi: 10.1016/j.neuropharm.2014.12.023. [Epub ahead of print]
2. Kakkar AK and Dahiya N. Drug treatment of obesity: current status and future prospects. Eur. J. Intern. Med. 2015 Jan 26. doi: 10.1016/j.ejim.2015.01.005. [Epub ahead of print]
3. Halpern B and Halpern A. Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications. Expert. Opin. Drug. Saf. 2015; 14: 305-15.
4. Taylor JR, Dietrich E and Powell JG. Update on obesity pharmacotherapy. Ann. N. Y. Acad. Sci. 2014; 1311: 1-13.
5. Yanovski SZ and Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. J.A.M.A. 2014; 311: 74-86.
6. Sweeting AN, Tabet E, Caterson ID and Markovic TP. Management of obesity and cardiometabolic risk-role of phentermine/extended release topiramate. Diabetes Metab. Syndr. Obes. 2014; 7: 35-44.
7. Jung HS, Lim Y and Kim EK. Therapeutic phytogenic compounds for obesity and diabetes. Int. J. Mol. Sci. 2014; 15: 21505-37.
8. Jungbauer A and Medjakovic S. Antiinflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. Maturitas 2012; 71: 227-39.
9. Mattes RD. Spices and energy balance. Physiol. Behav. 2012; 107: 584-90.
10. Jindal A, Whaley-Connell A, Brietzke S and Sowers JR. Therapy of obese patients with cardiovascular disease. Curr. Opin. Pharmacol. 2013; 13: 200-4.
11. Astrup A, Kristensen M, Gregersen NT, Belza A, Lorenzen JK, Due A and Larsen TM. Can bioactive foods affect obesity? Ann. N. Y. Acad. Sci. 2010; 1190: 25-41.
12. Yu R, Kim CS and Kang JH. Inflammatory components of adipose tissue as target for treatment of metabolic syndrome. Forum. Nutr. 2009; 61: 95-103.
13. Kim JY and Kwon O. Culinary plants and their potential impact on metabolic overload. Ann. N. Y. Acad. Sci. 2011; 1229: 133-9.
14. Hosseinzadeh H and Nassiri-Asl M. Avicenna's (Ibn Sina) the Canon of Medicine and saffron (Crocus sativus): a review. Phythother. Res. 2013; 27: 475-83.
15. Javadi B, Sahebkar A and Emami SA. A survey on saffron in major Islamic traditional books. Iran. J. Basic Med. Sci. 2013; 16: 1-11.
16. Srivastava R, Ahmed H, Dixit RK, Dharamveer and Saraf SA. Crocus sativus L.: a comprehensive review. Pharmacogn. Rev. 2010; 4: 200-8.
17. Kamalipour M and Akhondzadeh S. Cardiovascular effects of saffron: an evidencebased review. J. Tehran Heart Cent. 2011; 6: 59-61.
18. Asdaq SM and Inamdar MN. Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats. Appl. Biochem. Biotechnol. 2010; 162: 358-72.
19. Kianbakht S and Hajiaghaee R. Antihyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxaninduced diabetic rats. J. Med. Plants 2011; 10: 82-9.
20. Rajaei Z, Hadjzadeh MA, Nemati H, Hosseini M, Ahmadi M and Shafiee S. Antihyperglycemic and antioxidant activity of crocin in streptozocin-induced diabetic rats. J. Med. Food. 2013; 16: 206-10.
21. Shirali S, Zahra Bathaie S and Nakhjavani M. Effect of crocin on the insulin resistance and lipid profile of streptozocin-induced diabetic rats. Phytother. Res. 2013; 27: 1042-7.
22. Fadai F, Mousavi B, Ashtari Z, Ali beigi N, Farhang S, Hashempour S, Shahhamzei N and Bathaie SZ. Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study. Pharmacopsychiatry 2014; 47: 156-61.
23. Gout B, Bourges C and Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr. Res. 2010; 30: 305-13.
24. Mashmoul M, Azlan A, Khaza'ai H, Yusof BNM and Noor SM. Saffron: a natural potent antioxidant as a promising anti-obesity drug. Antioxidants 2013; 2: 293-308.
25. Vickers SP and Clifton PG. Animal models to explore the effects of CNS drugs on food intake and energy expenditure. Neuropharmacol. 2012; 63: 124-31.
26. D'Amelio, Sr. FS. Botanicals. CRC Press LLC. USA. 1999, pp: 39-41.
27. Vogel HG. Drug discovery and evaluation. 2nd ed. Springer. Germany. 2002, p: 1065.
28. Ramadan A, Soliman G, Mahmoud SS, Nofal SM and Abdel-Rahman RF. Evaluation of the safety and antioxidant activities of Crocus sativus and Propolis ethanolic extracts. J. Saudi Chem. Soc. 2012; 16: 13-21.
29. Hosseinzadeh H, Shariaty VM, Khadem Sameni A and Vahabzadeh M. Acute and subacute toxicity of crocin, a constituent of Crocus sativus L. (saffron), in mice and rats. Pharmacologyonline 2010; 2: 943-51.
30. Mattu HS and Randeva H. Role of adipokines in cardiovascular disease. J. Endocrinol. 2013; 216: T17-36.
31. Kwon H and Pessin JE. Adipokines mediate inflammation and insulin resistance. Front. Endocrionl. (Lousanne) 2013; 4: 71.
32. Knights AJ, Funnel AP, Pearson RC, Crossley M and Bell-Anderson KS. Adipokines and insulin action: a sensitive issue. Adipocyte 2014; 3: 88-96.
33. Askari H, Tykodi G, Liu J and Dagogo-Jack S. Fasting plasma leptin level is a surrogate measure of insulin sensitivity. J. Clin. Endocrinol. Metab. 2010; 95: 3836-43.
34. Lee IA, Lee JH, Baek NI and Kim DH. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biol. Pharm. Bull. 2005; 28: 2106-10.
35. Sheng L, Qian Z, Zheng S and Xi L. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. Eur. J. Pharmacol. 2006; 543: 116-22.
36. Xi L, Qian Z, Du P and Fu J. Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats. Phytomedicine 2007; 14: 633-6.